Clinical features for diagnosis and management of patients with PRDM12 congenital insensitivity to pain

J Med Genet. 2016 Aug;53(8):533-5. doi: 10.1136/jmedgenet-2015-103646. Epub 2016 Mar 14.

Abstract

Background: Congenital insensitivity to pain (CIP) is a rare extreme phenotype characterised by an inability to perceive pain present from birth due to lack of, or malfunction of, nociceptors. PRDM12 has recently been identified as a new gene that can cause CIP. The full phenotype and natural history have not yet been reported.

Methods: We have ascertained five adult patients and report their clinical features.

Results: Based on our findings, and those of previous patients, we describe the natural history of the PRDM12-CIP disorder, and derive diagnostic and management features to guide the clinical management of patients.

Conclusions: PRDM12-CIP is a distinct and diagnosable disorder, and requires specific clinical management to minimise predictable complications.

Keywords: charcot's joints; insensitivity to pain; keratitis; neuropathy; staphylococcus.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Carrier Proteins / genetics*
  • Female
  • Genetic Predisposition to Disease / genetics
  • Humans
  • Male
  • Middle Aged
  • Nerve Tissue Proteins / genetics*
  • Pain / diagnostic imaging*
  • Pain / genetics*
  • Pain Insensitivity, Congenital / diagnosis*
  • Pain Insensitivity, Congenital / genetics*
  • Young Adult

Substances

  • Carrier Proteins
  • Nerve Tissue Proteins
  • Prdm12 protein, human